New Delhi, Dec 24 (IANS) A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).The team from the University of California-Davis, US, tested an anti-inflammatory and anti-fibrotic monoclonal antibody known as nebokitug and found it to be safe and potentially effective in patients with PSC.Published in the American Journal of Gastroenterology, the results offer encouraging news for patients with PSC, for which there are…
Trending
- Jetlee (2026) Review: Satya Steals the Sky in This Turbulent But Fun Telugu Action-Comedy
- Glory (2026) Review: A Riveting Sports Drama That Packs a Powerful Punch
- Undekhi Season 4 Review: Darker, Deeper, and More Gripping Than Ever
- Sapne Vs Everyone Season 2 Review: A Raw, Riveting Tale of Dreams, Ambition & Survival
- KD: The Devil 2026 Review: Dhruva Sarja’s Underworld Epic Is a Bold, Ambitious Saga
- Patriot (2026) Movie Review: Mammootty and Mohanlal’s Legendary Reunion Delivers a Gripping Surveillance Thriller
- Kara Movie Review: Dhanush Delivers a Gripping Slow-Burn Thriller You Cannot Miss
- Raja Shivaji (2026) Movie Review: Riteish Deshmukh’s Grand Epic Is a Majestic Tribute to the Warrior King